Clinical Characteristics of Parkinsonism in HTLV ‐1‐Associated Myelopathy
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Mika Dozono und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. Hauptthemen laut MEDLINE: Paraparesis, Tropical Spastic, Parkinsonian Disorders, HTLV-I Infections. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the classic neurological manifestation of HTLV‐1 infection; however, this virus has also been associated with other neurological disorders. Concurrent parkinsonism is relatively rare and presents diagnostic challenges. The present study aimed to identify the clinical characteristics of HAM/TSP with parkinsonism.
Methods
This retrospective study included HAM/TSP patients hospitalized in Kagoshima University Hospital from January 2000 to March 2022. Clinical and laboratory findings of the HAM/TSP patients with parkinsonism (P‐HAM) were collected from the medical records and compared with HAM/TSP patients without parkinsonism (typical HAM/TSP [T‐HAM]). P‐HAM cases were defined as patients presenting with any combination of rigidity, resting tremor, bradykinesia, and/or postural instability, with these symptoms not attributed to HAM/TSP.
Results
Of 246 HAM/TSP patients, 11 (4.5%) presented with parkinsonism. Compared with T‐HAM, the age of onset was significantly older (65.0 vs. 48.8 years, p = 0.001) in patients with P‐HAM. Moreover, despite a shorter illness duration (8.5 vs. 12.5 years, p = 0.151), the Osame Motor Disability Score was significantly higher in P‐HAM cases than in T‐HAM cases (6.3 vs. 4.6, p = 0.0132), and all P‐HAM cases had scores ≥ 4. Laboratory findings showed no differences between the groups.
Interpretation
In our cohort, 4.5% of HAM/TSP patients had concomitant parkinsonism, which was associated with a later age of onset and greater disease severity. The coexistence of parkinsonism in HAM/TSP may be underrecognized, and our findings expand the clinical spectrum of neurological disease with HTLV‐1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
- Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
ORCID-Profile: Mika Dozono, Satoshi Nozuma
Zitieren
APA
Dozono, M., Nozuma, S., Hirakata, S., Yoshida, T., Kodama, D., Tanaka, M., Matsuura, E., Kubota, R., & Takashima, H. (2025). Clinical Characteristics of Parkinsonism in HTLV ‐1‐Associated Myelopathy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70121
Vancouver
Dozono M, Nozuma S, Hirakata S, Yoshida T, Kodama D, Tanaka M, et al. Clinical Characteristics of Parkinsonism in HTLV ‐1‐Associated Myelopathy. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70121
BibTeX
@article{Dozono2025,
author = {Dozono, Mika and Nozuma, Satoshi and Hirakata, Shota and Yoshida, Takashi and Kodama, Daisuke and Tanaka, Masakazu and Matsuura, Eiji and Kubota, Ryuji and Takashima, Hiroshi},
title = {Clinical Characteristics of Parkinsonism in HTLV ‐1‐Associated Myelopathy},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.70121}
}
EUVIMED